Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oximinoarylsulfonamide is an experimental small molecule compound characterized by the presence of both oxime and aryl sulfonamide functional groups. Its chemical formula is C34H46N6O6S2 and it has a molecular weight of approximately 698.9 g/mol[1][2]. The compound’s structure allows for diverse biological activities due to the dual functionality of the oxime (which can enhance selectivity and potency) and sulfonamide moieties (well-known for antibacterial activity via inhibition of bacterial folate synthesis)[4][5]. While specific clinical indications or mechanisms are not established for this particular molecule, derivatives in this class have shown potential anti-inflammatory and antitumor properties in addition to their classic antibacterial effects[4][7]. Oximinoarylsulfonamides are primarily used as research tools or building blocks in medicinal chemistry rather than as approved pharmaceuticals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oximinoarylsulfonamide.